| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/20/2005 | CN1211126C Vascular endothelial growth factor 2 |
| 07/20/2005 | CN1211123C Humanized antibodies against leukocyte adhesion molecule VLA-4 |
| 07/19/2005 | US6919497 Producing a soybean plant produced by crossing the cultivar with itself or another soybean variety; hybrid soybean seeds and plants produced by crossing the cultivar and another cultivar |
| 07/19/2005 | US6919495 For control of plant gene expression; plant promoters |
| 07/19/2005 | US6919494 Propagating preferential corn plants; obtain corn embryos, incubate in nutrient broth, propagate recover plants |
| 07/19/2005 | US6919493 Sugar-regulatory sequences in alpha-amylase genes |
| 07/19/2005 | US6919466 Genes for microsomal delta-12 fatty acid desaturases and related enzymes from plants |
| 07/19/2005 | US6919445 Detecting with a multicolor fluorescent dyes, for automated 4-DNA sequencing systems, identifying the classes of the polynucleotides |
| 07/19/2005 | US6919444 Magnetic particles for purifying nucleic acids |
| 07/19/2005 | US6919443 Using enzymatic cleavage of nucleotide sequences to prepare library of microsatellite sequences; genetic mapping; DNA fingerprinting; molecular markers |
| 07/19/2005 | US6919440 Mannosyl transfer with regeneration of GDP-mannose |
| 07/19/2005 | US6919439 Derivatized oligonucleotides having improved uptake and other properties |
| 07/19/2005 | US6919438 Comprises viral expression vector coding envelope protein domains for use as gene therapeutic tool in the treatment of autoimmune diseases |
| 07/19/2005 | US6919435 Comprises cancer marker glycoprotein for diagnosis of stomach, colon and breast cancers |
| 07/19/2005 | US6919432 Substances and their uses |
| 07/19/2005 | US6919431 Comprises soluble n-ethylmaleimide sensitive fusion protein attachment proteins (SNAPS) for treatment and prevention of tumors, blood, viral autoimmune and inflammatory diseases |
| 07/19/2005 | US6919430 Comprises beta-galactoside-binding lectin for treatment and prevention of tumors, blood, viral autoimmune and inflammatory diseases |
| 07/19/2005 | US6919427 Mimetic protein for modulating protein binding activity and treatment and prevention of cancer, blood, viral, inflammatory and autoimmune diseases |
| 07/19/2005 | US6919425 Isolation of a cell-specific internalizing peptide that infiltrates tumor tissue for targeted drug delivery |
| 07/19/2005 | US6919318 Enhancing immune responses to genetic immunization by using a chemokine |
| 07/19/2005 | US6919311 Containing modifications in the A3 and/or C1 and/or C2 domains of the sequence of the light chain of Factor VIII |
| 07/19/2005 | US6919209 Using adeno-associated viral vector to stably transduce pluripotent progenitor cells with high efficiency; genetic engineering and heterologous gene expression; gene therapy |
| 07/19/2005 | US6919208 Methods and compositions for enhancing the delivery of a nucleic acid to a cell |
| 07/19/2005 | US6919207 Noninvasive; gene therapy; introducing electromagnetic field response elements into a gene promoter to serve as switches for regulating exogenously introduced genes; and applying electromagnetic field to induce gene expression. |
| 07/19/2005 | US6919206 Medium containing flt3 ligand for culturing hematophoietic cells |
| 07/19/2005 | US6919204 Modulation of gene expression using localization domains |
| 07/19/2005 | US6919199 Microbes and methods for remediation |
| 07/19/2005 | US6919198 Transgenic gram-negative bacterial strain comprising yersinia signal sequences for expressing heterologous fusion proteins in periplasm |
| 07/19/2005 | US6919196 Parvovirus NS1 variants |
| 07/19/2005 | US6919195 Enzymatic polypeptide for use in food processing |
| 07/19/2005 | US6919192 Human kinases and polynucleotides encoding the same |
| 07/19/2005 | US6919186 Fluorescent proteins |
| 07/19/2005 | US6919183 Detecting and isolating cells that produce preferential protein; obtain cells, transfrom cells with vector containing preferential protein, detect protein on surface of cell, isolate cells displaying preferential protein |
| 07/19/2005 | US6919180 Hybridization rate enhancement for substrate-bound specific nucleic acid-binding agents |
| 07/19/2005 | US6919177 Screening animal for preferential meat qualities; obtain tissue sample, extract nucleotide sequences, detect geneotype associated with litter size, screen for polymorphism |
| 07/19/2005 | US6919175 Using magnetic particles to extract and recover nucleotide sequences from bodily fluids |
| 07/19/2005 | US6919174 Methods for disease detection |
| 07/19/2005 | US6919091 Compositions and methods for drug delivery using pH sensitive molecules |
| 07/19/2005 | US6919086 Graminae pollen allergen mutants for specific immunotherapy, and production and use of the same |
| 07/19/2005 | US6919085 E2 subunit vaccine comprising recombinant pestivirus E2 protein |
| 07/19/2005 | US6919080 Polypeptide for use in the treatment of respiratory disorders in poultry |
| 07/19/2005 | US6919079 FcεPE chimeric protein for targeted treatment of allergy responses, a method for its production and pharmaceutical compositions containing the same |
| 07/19/2005 | US6919075 Bacteriophage displaying aβ epitopes and method of use |
| 07/19/2005 | CA1341486C Modified protein a |
| 07/16/2005 | CA2493054A1 Detection of enterovirus nucleic acid |
| 07/14/2005 | WO2005064019A2 Universal amplification of fragmented rna |
| 07/14/2005 | WO2005064016A1 Method of multiplex microorganism detection |
| 07/14/2005 | WO2005064010A1 Composition for binding a nucleic acid to a solid phase |
| 07/14/2005 | WO2005063998A2 Maize metallothionein 2 promoter and methods of use |
| 07/14/2005 | WO2005063997A2 Maize metallothionein promoter |
| 07/14/2005 | WO2005063996A2 Plant activation of insect toxin |
| 07/14/2005 | WO2005063995A2 Sugar and lipid metabolism regulators in plants vi |
| 07/14/2005 | WO2005063994A1 Puroindoline-a inducible promoter |
| 07/14/2005 | WO2005063993A1 Artificial bidirectional promoter for activation of gene expression |
| 07/14/2005 | WO2005063992A1 Novel serum type streptococcus mutans and utilization of the same |
| 07/14/2005 | WO2005063990A2 Wuschel (wus) gene homologs |
| 07/14/2005 | WO2005063989A1 Promoter nucleotidic sequences inducible by infection by pathogens |
| 07/14/2005 | WO2005063988A1 Alteration of oil traits in plants |
| 07/14/2005 | WO2005063987A1 Gp153: methods and compositions for treating cancer |
| 07/14/2005 | WO2005063985A1 Probe set and method for identifying hla allele |
| 07/14/2005 | WO2005063984A1 Double-stranded dna inhibiting gene expression |
| 07/14/2005 | WO2005063983A1 Modulators of bone homeostasis identified in a high-throughput screen |
| 07/14/2005 | WO2005063982A1 Method of detecting target substance |
| 07/14/2005 | WO2005063980A1 METHOD OF ENZYMATICALLY CONSTRUCTING RNAi LIBRARY |
| 07/14/2005 | WO2005063979A1 Cell extract for high-functioned cell-free protein synthesis and method of preparing the extract |
| 07/14/2005 | WO2005063978A1 Fraction and antibody comprising guinea pig immunoglobulin e |
| 07/14/2005 | WO2005063976A2 Methods for inducing differentiation of undifferentiated mammalian cells into osteoblasts |
| 07/14/2005 | WO2005063970A1 Methods for producing a549 cell lines stable in serum-free medium suspension culture |
| 07/14/2005 | WO2005063964A1 Fkbp type ppiase, expression vector, transformant, fused protein, method of producing fused protein, method of producing target protein, method of purifying kfbp type ppiase and method of purifying fused protein |
| 07/14/2005 | WO2005063820A2 Il-7 fusion proteins |
| 07/14/2005 | WO2005063817A2 Methods for identifying functional antibodies |
| 07/14/2005 | WO2005063816A2 Monovalent antibody fragments useful as therapeutics |
| 07/14/2005 | WO2005063807A2 Treatment of coronary or peripheral ischemia |
| 07/14/2005 | WO2005063802A2 Haemophilus influenzae type iv pili |
| 07/14/2005 | WO2005063801A2 Method for decreasing the contact between hepta-repeat region s of the corona-virus spike proteins and use thereof |
| 07/14/2005 | WO2005063798A1 Identification of two linear epitopes on ebola or marburg virus glycoproteins critical for infection |
| 07/14/2005 | WO2005063783A1 Use of a low-oxygen environment in plant transformation |
| 07/14/2005 | WO2005063612A1 Fine metal structure, process for producing the same, fine metal mold and device |
| 07/14/2005 | WO2005063302A1 Drug for preventing or treating heart diseases comprising cd9 gene |
| 07/14/2005 | WO2005063283A1 Vaccine comprising recombinant clpp protein of streptococcus pneumoniae |
| 07/14/2005 | WO2005063279A1 Means for stimulation and activation of hair growth by il-15 |
| 07/14/2005 | WO2005063264A1 Immunopotentiator and method of enhancing immunological activity with the same |
| 07/14/2005 | WO2005063170A2 Methods of identifying immunoregulatory agents, immunoregulatory agents, and uses thereof |
| 07/14/2005 | WO2005063007A1 Non-human mammal comprising a modified serca2 gene and methods, cells, genes, and vectors thereof |
| 07/14/2005 | WO2005062995A2 INHIBITION OF CALCIUM-INDEPENDENT PHOSPHOLIPASES A2β OR A2Ϝ INHIBIT HORMONE-INDUCED DIFFERENTIATION OF 3T3-L1 PREADIPOCYTES |
| 07/14/2005 | WO2005062957A2 Compositions and methods for combined therapy of disease |
| 07/14/2005 | WO2005062947A2 Methods and compositions for identifying rna-binding proteins |
| 07/14/2005 | WO2005062942A2 Novel oligonucleotides and treating cardiac disorders by using the same |
| 07/14/2005 | WO2005062937A2 Methods and compositions for enhancing the efficacy and specificity of single and double blunt-ended sirna |
| 07/14/2005 | WO2005062890A2 Methods of treating cardiac disorders by suppressing the expression of the potassium inwardly-rectifying channel |
| 07/14/2005 | WO2005062881A2 Gene therapy using transposon-based vectors |
| 07/14/2005 | WO2005062867A2 Novel carotenoids ketolases |
| 07/14/2005 | WO2005062854A2 Polyamides for nucleic acid delivery |
| 07/14/2005 | WO2005062820A2 Multi plasmid system for the production of influenza virus |
| 07/14/2005 | WO2005062812A2 A rAAV-BASED SYSTEM FOR SOMATIC CELL GENE DISRUPTION |
| 07/14/2005 | WO2005062780A2 In vivo odorant receptor systems and their uses |
| 07/14/2005 | WO2005062767A2 Hoxd3, hoxa3, and hoxb3 compositions and methods for improved wound healing |
| 07/14/2005 | WO2005053505A3 Use of gene ncsag4 for the diagnosis and prevention of neosporosis and as a marker for analysis of the pathogenesis |
| 07/14/2005 | WO2005051351A3 Gene delivery mediated by liposome-dna complex with cleavable peg surface modification |
| 07/14/2005 | WO2005045038A8 RNA INTERFERENCE MEDIATED INHIBITION OF GPRA AND AAA1 GENE EXPRESSION USING SHORT NUCLEIC ACID (siNA) |